Startups Building an Anti-metastatic Drug Platform and AI to Fill Small Hotels win CHF 40,000
19.06.2019
Venture Kick’s jury rewards medtech spin-off Invasight and ICT startup RoomPriceGenie for innovations to improve the treatment of metastatic cancer and harness artificial intelligence to increase the occupancy rate of small hotels.
1.jpg) |
 |
 Invasight's co-founders Samuel Fulcher and Karthiga Santhana Kumar
|
|
 RoomPriceGenie's co-founder Marvin Speh
|
|
Invasight: anti-metastatic drug discovery
Cancer metastasis, the dissemination and propagation of cancer cells distant from the primary tumor site, is the leading of cause of cancer-associated mortality. Automated cell dissemination counter is an innovative technology for anti-invasion drug discovery, developed through years of research at the University Children’s Hospital Zurich and University of Zürich. Postdoc Karthiga Santhana Kumar is transforming her research into a drug discovery platform to change the way we study, treat and design drugs to combat cancer metastasis. Venture Kick’s support will be used by Invasight for market research and marketing.
www.venturekick.ch/Invasight
RoomPriceGenie: dynamic pricing for small hotels
Revenue management for many small hotels merely means a high-season and a low-season. That old-fashioned approach doesn't make sense to co-founders Ari Andricopoulos, author of 49 Tips to Supercharge your Revenue, Marvin Speh, and Jörg Siegel. The trio, linked to the ETH, the University of St. Gallen, and the Karlsruhe Institute of Technology, blend backgrounds in the travel, finance and data industries. They are refining an algorithm to help small hotels fill their rooms throughout the year and increase revenue by as much as 15 percent. Venture Kick’s support will be used to scale RoomPriceGenie’s B2B2B business model, explore more sales channels and expand the global sales team.
www.venturekick.ch/roompricegenie
Cancer metastasis, the dissemination and propagation of cancer cells distant from the primary tumor site, is the leading of cause of cancer-associated mortality. Automated cell dissemination counter is an innovative technology for anti-invasion drug discovery, developed through years of research at the University Children’s Hospital Zurich and University of Zürich. Postdoc Karthiga Santhana Kumar is transforming her research into a drug discovery platform to change the way we study, treat and design drugs to combat cancer metastasis. Venture Kick’s support will be used by Invasight for market research and marketing.
www.venturekick.ch/Invasight
RoomPriceGenie: dynamic pricing for small hotels
Revenue management for many small hotels merely means a high-season and a low-season. That old-fashioned approach doesn't make sense to co-founders Ari Andricopoulos, author of 49 Tips to Supercharge your Revenue, Marvin Speh, and Jörg Siegel. The trio, linked to the ETH, the University of St. Gallen, and the Karlsruhe Institute of Technology, blend backgrounds in the travel, finance and data industries. They are refining an algorithm to help small hotels fill their rooms throughout the year and increase revenue by as much as 15 percent. Venture Kick’s support will be used to scale RoomPriceGenie’s B2B2B business model, explore more sales channels and expand the global sales team.
www.venturekick.ch/roompricegenie